The volatile landscape of medical stop-loss insurance premiums, a critical protection for self-insured employers against catastrophic healthcare costs, is anticipated to enter a period of stability after 2027, according to Brian Evanko, the president of Cigna. Evanko shared this significant projection recently in Las Vegas, during a prominent healthcare conference organized by Bank of America Securities, offering a beacon of hope for businesses grappling with escalating healthcare expenditures. This forecast arrives after a tumultuous period marked by an unexpected and substantial surge in claims that compelled insurers to implement significant premium adjustments across the industry.
The Unforeseen Challenge: The 2024 Claims Surge and Its Aftermath
The genesis of the current premium volatility can be traced back to late 2024, when stop-loss insurers began reporting an unanticipated and significant increase in claims. This surge caught many in the industry off guard, leading to a scramble to reassess risk and adjust pricing models. Evanko candidly described 2024 as "a difficult year for us, where claim costs exceeded our expectations rather meaningfully." This sentiment was not unique to Cigna, as evidenced by similar reports from other major players in the stop-loss market, signaling an industry-wide phenomenon.
The nature of this surge in claims is multifaceted, likely encompassing a combination of factors that have been impacting the broader U.S. healthcare system. Experts suggest potential contributors include a rebound in deferred care post-pandemic, an increase in utilization of high-cost specialty drugs, advancements in medical technology leading to more expensive treatments, and general healthcare inflation that consistently outpaces the overall Consumer Price Index. For self-insured employers, who bear the direct financial risk of their employees’ healthcare costs up to a certain threshold, such a sudden spike in claims translates directly into higher stop-loss premiums, which are designed to protect them from individual or aggregate claims exceeding predetermined limits.
The timing of this claim escalation presented a unique challenge for insurers. The magnitude of the unexpected costs incurred in 2024 emerged too late for Cigna, and likely many of its peers, to fully incorporate these new realities into their 2025 pricing structures. This created a lag effect, where the financial impact of the higher claims had to be absorbed, setting the stage for subsequent, more aggressive repricing actions.
Cigna’s Strategic Repricing Journey: A Multi-Year Adjustment (2025-2027)
In response to the unprecedented claim environment, Cigna embarked on a carefully orchestrated, multi-year repricing strategy aimed at restoring actuarial soundness and margin stability to its stop-loss portfolio. This strategic initiative, outlined by Evanko, provides a clear timeline for the anticipated market correction:
-
2025: The Transitional Year: Evanko characterized 2025 as "a bit of a cutover year, or transitional year." This period likely involved initial, albeit incomplete, adjustments to premiums as insurers began to digest the full extent of the 2024 claims surge. For employers, this meant the beginning of an upward trend in renewal rates, though perhaps not yet fully reflecting the underlying cost increases. Insurers were in the process of recalibrating their underwriting models and actuarial assumptions to align with the new claims environment. This phase was crucial for setting the groundwork for more comprehensive adjustments in subsequent years.
-
2026: Sizable Increases and Client Retention: The year 2026 has witnessed the most significant premium adjustments. Evanko noted, "In 2026, we’ve been able to get sizable price increases." This phase represents a full recognition of the elevated claim costs and the necessary corrective measures to ensure the long-term viability of stop-loss offerings. A key success factor highlighted by Evanko was Cigna’s ability to retain clients despite these "higher-than-historical price increases." This speaks to the essential nature of stop-loss coverage for self-insured employers, who recognize the critical protection it provides against potentially bankrupting medical events. It also suggests that Cigna’s pricing, while higher, remained competitive relative to the market and justifiable given the underlying cost pressures. The strong client retention indicates that employers understood the necessity of these adjustments in a challenging market.
-
2027: Finalizing Margin Recovery and Repricing Completion: The final phase of Cigna’s repricing strategy is slated for 2027. "Then ’27 will be the final year of the margin recovery on our stop-loss portfolio. In ’27, we’ll complete the stop-loss repricing," Evanko confirmed. This statement indicates that by the end of 2027, Cigna expects to have fully recalibrated its pricing to adequately cover current and projected claim costs, achieving sustainable margins for this line of business. For employers, this implies that while 2027 renewals may still reflect increases, they will mark the culmination of the aggressive repricing cycle, paving the way for a more stable premium environment thereafter. This completion of the repricing signals a return to a more predictable and actuarially sound market.
Market Leadership and the Competitive Landscape
Cigna’s pronouncement carries significant weight given its formidable position in the stop-loss market. Evanko asserted that Cigna is "the biggest stop-loss issuer overall," with an impressive approximately $8 billion in annual stop-loss premiums. This substantial market share not only underscores Cigna’s influence but also suggests that its pricing strategies and market outlook can often serve as a bellwether for the broader industry. Such a dominant player completing its repricing strategy provides a strong signal of future market direction.
The trends observed by Cigna are not isolated. Evanko’s comments align with sentiments expressed by other major stop-loss providers. Companies like Sun Life Financial and Voya Financial have similarly discussed with their investors the significant increase in costs experienced in 2024. Crucially, both companies have indicated that while 2024 was challenging, they believe the current increases in claims are now in line with the assumptions used to set their 2026 prices. This convergence of experience and outlook among leading insurers lends credibility to Evanko’s prediction of post-2027 stabilization, suggesting a market-wide recalibration rather than an isolated corporate strategy. The shared experience reinforces the notion that the 2024 surge was a systemic shock rather than an idiosyncratic event.
Demystifying Medical Stop-Loss Insurance: A Crucial Shield for Employers
To fully appreciate the impact of these premium fluctuations and the significance of Evanko’s announcement, it’s essential to understand the role of medical stop-loss insurance. This specialized form of coverage is designed exclusively for self-insured health plans, which are prevalent among mid-sized to large employers in the United States. In a self-insured model, the employer directly pays for employees’ medical claims out of its own funds, rather than paying a fixed premium to an insurance carrier to assume that risk. This approach offers several advantages, including greater control over plan design, access to claims data for better cost management, and the potential for significant cost savings if claims are lower than anticipated.
However, self-insurance also carries the inherent risk of unpredictable, high-cost claims. A single catastrophic illness, a complex surgery, or a prolonged hospital stay for one or more employees can quickly deplete an employer’s healthcare budget, potentially leading to severe financial strain. This is where medical stop-loss insurance steps in. It acts as a financial safeguard, protecting the employer from the brunt of these extraordinarily high claims.
Stop-loss policies typically come in two main forms:
- Specific Stop-Loss: This protects the employer from individual claims exceeding a predetermined dollar amount, known as the "specific deductible" or "attachment point." For example, if a policy has a $100,000 specific deductible, the stop-loss insurer will reimburse the employer for any costs incurred by a single employee that exceed $100,000 in a policy year.
- Aggregate Stop-Loss: This provides protection if the total claims for the entire employee population exceed a certain aggregate limit over the policy year. This limit is usually calculated as a percentage (e.g., 125%) of the expected total claims.
The premiums for stop-loss insurance are determined by various factors, including the size and demographics of the employee population, the chosen deductible levels, the industry, and historical claims experience. When overall healthcare costs rise, particularly for high-cost claims that breach specific deductibles, stop-loss insurers face higher payouts, necessitating an increase in the premiums they charge to employers to maintain solvency and profitability. This direct correlation explains why the 2024 claims surge had such a profound and immediate effect on stop-loss premiums.
Implications for Self-Insured Employers and Benefits Advisors
Evanko’s projection of stabilization after 2027 offers a welcome respite for self-insured employers and the benefits advisors who guide them. For several years, employers have navigated a challenging environment characterized by unpredictable and rapidly escalating stop-loss renewal quotes. This period of "sticker shock," as the original article terms it, has necessitated elaborate budgeting rituals, rigorous negotiations, and often difficult decisions regarding benefit design and employee cost-sharing.
The prospect of stable premiums starting in 2028 suggests a return to more predictable budgeting cycles. Employers can anticipate a period where renewal increases are more modest and aligned with general healthcare inflation rather than dramatic corrections. This predictability allows for more effective long-term financial planning and greater confidence in maintaining robust benefit packages for employees.
Benefits advisors play a crucial role during periods of market volatility. They help employers understand the drivers of premium increases, explore alternative plan designs, and negotiate effectively with carriers. The impending stabilization will allow advisors to shift their focus from crisis management to strategic optimization, helping clients leverage data analytics for better cost control, explore wellness programs, and assess value-based care models, all within a more predictable cost framework.
However, the period leading up to 2028 will still require diligence. Employers renewing their stop-loss policies in 2026 and 2027 should anticipate continued, albeit potentially tapering, premium increases as insurers complete their repricing cycles. Proactive engagement with advisors, thorough market analysis, and a clear understanding of their own claims data will remain paramount during this transitional phase.
Broader Healthcare Cost Dynamics and Cigna’s Future Direction
The fluctuations in stop-loss premiums are intrinsically linked to the broader dynamics of healthcare costs in the United States. The persistent rise in medical expenditures, driven by factors such as an aging population, prevalence of chronic diseases, high cost of prescription drugs (especially specialty pharmaceuticals), increased utilization of advanced medical technologies, and administrative complexities, creates an upward pressure across the entire healthcare ecosystem. Stop-loss insurance, by its nature, is particularly sensitive to the most expensive claims, making it a critical barometer for the escalating cost of severe illnesses and complex treatments.
As the industry grapples with these overarching trends, Cigna’s strategic direction under its new leadership will be closely watched. Brian Evanko is slated to succeed David Cordani as Cigna’s CEO on July 1. His detailed commentary on the stop-loss market, delivered in a prominent public forum, not only provides transparency but also offers an early glimpse into his strategic priorities and his nuanced understanding of key segments of Cigna’s business. His focus on achieving margin recovery and then stabilizing premiums for such a critical product line underscores the importance of financial discipline and long-term client relationships in Cigna’s future vision. The ability to navigate significant market challenges while maintaining client retention, as demonstrated in 2026, speaks to a leadership approach that balances financial imperatives with market responsiveness.
Looking Ahead: The Promise of 2028 and Beyond
The announcement from Cigna’s President, Brian Evanko, marks a pivotal moment for the medical stop-loss insurance market. While the period from late 2024 through 2027 has been characterized by significant premium adjustments in response to an unexpected surge in claims, the industry is now signaling a light at the end of the tunnel. The completion of comprehensive repricing strategies by major carriers, coupled with a reported alignment between current claims trends and 2026 pricing assumptions, paves the way for a more stable and predictable environment for self-insured employers.
For employers, the promise of less "sticker shock" on 2028 renewals represents an opportunity for renewed confidence in their healthcare budgeting and strategic planning. For the healthcare industry, it signifies a successful navigation through a period of unforeseen volatility, demonstrating the adaptive capacity of insurers to respond to dynamic cost pressures. As the market progresses toward 2028, stakeholders will be keenly observing whether this projected stability materializes, ushering in a new era of predictability for a crucial component of employer-sponsored healthcare. The detailed account provided by Cigna, supported by similar experiences across the industry, offers a robust framework for understanding the past challenges and the hopeful outlook for the future of medical stop-loss insurance.
